Skip to main content
. Author manuscript; available in PMC: 2013 Aug 21.
Published in final edited form as: Breast Cancer Res Treat. 2011 Nov 1;131(3):899–906. doi: 10.1007/s10549-011-1850-2

Table 2.

Treatment-related toxicities

Toxicity Grade 3: Number
(%)
Grade 4: Number
(%)
Neutropenia 12 (39) 8 (26)
Leukopenia 10 (32) 3 (10)
Diarrhea 10 (32) 0
Lymphopenia 8 (26) 0
Infection 6 (19) 0
Pain 4 (13) 0
Fatigue 4 (13) 0
Electrolyte
 abnormalities
4 (13)a 0
Pulmonary toxicity 2 (6)b 0
Neuropathy 2 (6) 0
Skin toxicity 2 (6) 0
Nausea/emesis 2 (6) 0
Elevated ALT 2 (6) 0
Prolonged PTT 2 (6) 0
Mucositis 1 (3) 0
Cardiac toxicity 0 0
Anemia 0 0
Thrombocytopenia 0 0
Other 3 (10)c 0

PTT partial thromboplastin time. ALT alanine transaminase

a

Hyponatremia, hypokalemia, hypophosphatemia

b

Dyspnea

c

Anorexia, dehydration